Literature DB >> 25350983

Prospects for droxidopa in neurogenic orthostatic hypotension.

Amanda J Ross1, Julian M Stewart2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25350983      PMCID： PMC5253701          DOI： 10.1161/HYPERTENSIONAHA.114.04204

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  7 in total

1.  Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome.

Authors:  Roy Freeman; Wouter Wieling; Felicia B Axelrod; David G Benditt; Eduardo Benarroch; Italo Biaggioni; William P Cheshire; Thomas Chelimsky; Pietro Cortelli; Christopher H Gibbons; David S Goldstein; Roger Hainsworth; Max J Hilz; Giris Jacob; Horacio Kaufmann; Jens Jordan; Lewis A Lipsitz; Benjamin D Levine; Phillip A Low; Christopher Mathias; Satish R Raj; David Robertson; Paola Sandroni; Irwin Schatz; Ron Schondorff; Julian M Stewart; J Gert van Dijk
Journal:  Clin Auton Res       Date:  2011-04       Impact factor: 4.435

2.  Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, double-blind multicenter study. Midodrine Study Group.

Authors:  P A Low; J L Gilden; R Freeman; K N Sheng; M A McElligott
Journal:  JAMA       Date:  1997-04-02       Impact factor: 56.272

Review 3.  L-dihydroxyphenylserine (Droxidopa): a new therapy for neurogenic orthostatic hypotension: the US experience.

Authors:  Horacio Kaufmann
Journal:  Clin Auton Res       Date:  2008-03-27       Impact factor: 4.435

Review 4.  Neurogenic orthostatic hypotension: a pathophysiological approach.

Authors:  David S Goldstein; Yehonatan Sharabi
Journal:  Circulation       Date:  2009-01-06       Impact factor: 29.690

5.  Effect of unnatural noradrenaline precursor on sympathetic control and orthostatic hypotension in dopamine-beta-hydroxylase deficiency.

Authors:  A J Man in 't Veld; F Boomsma; A H van den Meiracker; M A Schalekamp
Journal:  Lancet       Date:  1987-11-21       Impact factor: 79.321

6.  Randomized withdrawal study of patients with symptomatic neurogenic orthostatic hypotension responsive to droxidopa.

Authors:  Italo Biaggioni; Roy Freeman; Christopher J Mathias; Phillip Low; L Arthur Hewitt; Horacio Kaufmann
Journal:  Hypertension       Date:  2014-10-27       Impact factor: 10.190

7.  Functional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function part II: physiological and pharmacological manipulations and pathological alterations of locus coeruleus activity in humans.

Authors:  E R Samuels; E Szabadi
Journal:  Curr Neuropharmacol       Date:  2008-09       Impact factor: 7.363
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.